CN103919762A - Application for diminishing swelling and relieving itching caused by mosquito bite and preparation method - Google Patents
Application for diminishing swelling and relieving itching caused by mosquito bite and preparation method Download PDFInfo
- Publication number
- CN103919762A CN103919762A CN201410157035.6A CN201410157035A CN103919762A CN 103919762 A CN103919762 A CN 103919762A CN 201410157035 A CN201410157035 A CN 201410157035A CN 103919762 A CN103919762 A CN 103919762A
- Authority
- CN
- China
- Prior art keywords
- parts
- weight
- mosquito bite
- carbomer
- plaster
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention provides an application for diminishing swelling and relieving itching caused by mosquito bite and a preparation method. In summer, the parts bitten by mosquitoes itch and ache, especially the skins of children are delicate, not only itch and ache after being bitten by mosquitoes but also are easily infected and then are inflamed and ulcerated, and blood diseases are likely to be caused and lives are likely to be threatened when the conditions are serious. The application comprises 1-3 parts of nitrofurazone, 90-96 parts of carbomer, 3-7 parts of lidocaine, 1-3 parts of borneol and 1-4 parts of menthol in parts by weight. The application is used for diminishing swelling and relieving itching caused by mosquito bite.
Description
technical field:
the present invention relates to a kind of mosquito bite repellent antipruritic applies ointment or plaster and manufacture method.
background technology:
itched not only but also pain summer by the position of mosquito bite, particularly child's skin exquisiteness, by after mosquito bite not but itch and pain, be also easy to infect, inflammation is festered, serious meeting hematopathy, threat to life.
summary of the invention:
the object of this invention is to provide a kind of elimination that can be very fast is applied ointment or plaster and manufacture method by the caused swelling of mosquito bite, inflammation and the mosquito bite repellent antipruritic that festers.
above-mentioned object realizes by following technical scheme:
a kind of mosquito bite repellent antipruritic is applied ointment or plaster, its composition comprises: nitrofural, carbomer, lignocaine, Borneolum Syntheticum, Mentholum, the parts by weight of described nitrofural are 1-3, the parts by weight of described carbomer are 90-96, the parts by weight of described lignocaine are 3-7, the parts by weight of described Borneolum Syntheticum are 1-3, and the parts by weight of described Mentholum are 1-4.
described mosquito bite repellent antipruritic is applied ointment or plaster, the parts by weight of described nitrofural are 2, and the parts by weight of described carbomer are 94, and the parts by weight of described lignocaine are 5, the parts by weight of described Borneolum Syntheticum are 2, and the parts by weight of described Mentholum are 2.5.
described mosquito bite repellent antipruritic is applied ointment or plaster, the parts by weight of described nitrofural are 1, and the parts by weight of described carbomer are 92, and the parts by weight of described lignocaine are 3, the parts by weight of described Borneolum Syntheticum are 1, and the parts by weight of described Mentholum are 2.
described mosquito bite repellent antipruritic is applied ointment or plaster, the parts by weight of described nitrofural are 3, and the parts by weight of described carbomer are 96, and the parts by weight of described lignocaine are 6, the parts by weight of described Borneolum Syntheticum are 3, and the parts by weight of described Mentholum are 4.
described mosquito bite repellent antipruritic is applied ointment or plaster, the parts by weight of described nitrofural are 2.5, and the parts by weight of described carbomer are 95, and the parts by weight of described lignocaine are 6, the parts by weight of described Borneolum Syntheticum are 2.5, and the parts by weight of described Mentholum are 3.
described mosquito bite repellent antipruritic is applied ointment or plaster, and also comprises medical adhesive-bonded fabric and nontoxic transparent whites Polypropylence Sheet.
the manufacture method that a kind of mosquito bite repellent antipruritic is applied ointment or plaster, taking by weight described nitrofural, described carbomer, described lignocaine, described Borneolum Syntheticum, described Mentholum packs in container and stirs fully and make mastic, be applied to uniformly on medical adhesive-bonded fabric, thickness is 3-5mm, then cover upper nontoxic transparent whites Polypropylence Sheet, then be tailored into the bulk of 30-50 × 30-50 mm, finally pack packaging bag into.
the manufacture method that described mosquito bite repellent antipruritic is applied ointment or plaster, described bulk is 30 × 30 mm or 40 × 40 mm or 50 × 50 mm.
beneficial effect:
1. the nitrofural that the present invention adopts can be treated wound, burn, suppurative dermatitis, otitis media, dacryocystisis, vaginitis, bladder irrigation, decubital ulcer etc.
2. the carbomer that the present invention adopts is very important rheology control agent, carbomer after neutralization is outstanding gel-type vehicle, there is the important function such as thickening, suspension, technique is simple, good stability, carbomer (conventional amount used 0.25-0.5%) under very low consumption just can produce efficient thickening power, thereby prepare very emulsion, the cream frost of wide range of viscosities and various flows degeneration, again can reemulsification when moistening, easily preparation does not contain the waterproofing emulsion of film former, can make this product not trickle, docile is on skin well.
3. the lignocaine that the present invention adopts is very fast as local anesthetic onset, of flaccid muscles also better, surface anesthetic effect is 4 times of lidocaine hydrochloride, and infiltration anesthesia and spinal anesthesia act as 2 times of lidocaine hydrochloride, and conduction block act as 6 times of lidocaine hydrochloride; Antipruritic effect is good.
4. the Borneolum Syntheticum that the present invention adopts can be treated apoplexy locked mouth, calentura coma, and infantile convulsion expectorant fan, deafness with qi stagnation, sore throat, aphtha, otitis media, carbuncle, hemorrhoid, order is nebula film also, enterobiasis.Cure mainly trusted subordinate's pathogen, rheumatism is gathered, deafness.Can also treat interior external oculopathy eye, three worms, control five hemorrhoid, improving eyesight, relieving palpitation, secret essence; Improving eyesight, goes conjunctival congestion skin nebula; Treatment arthrodynia of extremities.Borneolum Syntheticum can lead to all keys, loose stagnated fire, and removing nebula improving eyesight, the similar Camphora of reducing swelling and alleviating pain effect, has the effect of pain relieving antiseptical; (dull and stereotyped mixing method) higher concentration (0.5%) has bacteriostasis in vitro, also can be used for neuralgia and antiinflammatory.Mucosa, subcutaneous tissue all easily absorb, and after being combined in vivo, excrete with glucuronic acid.
5. the Mentholum that the present invention adopts produces refrigerant sense for skin or mucosa and is not suitable for sense to alleviate, and cures mainly pain, as excitants, acts on skin or mucosa pharmaceutically, has refrigerant itching-relieving action; The carminative that can be used as for oral administration, for headache and nose; Pharynx; Laryngitis etc., directly act on skin or mucosa, have refrigerant antipruritic effect, also can be used for preventing epidemic virus sexuality to emit; Can also main anemopyretic cold; Headache; Conjunctival congestion; Laryngopharynx swelling and pain; Toothache; Skin pruritus etc.
6. the swelling at the position of the elimination mosquito bite that the present invention can be very fast, Quick itch stopping, antiinflammatory, detumescence.
detailed description of the invention:
embodiment 1:
a kind of mosquito bite repellent antipruritic is applied ointment or plaster, its composition comprises: nitrofural, carbomer, lignocaine, Borneolum Syntheticum, Mentholum, the parts by weight of described nitrofural are 1-3, the parts by weight of described carbomer are 90-96, the parts by weight of described lignocaine are 3-7, the parts by weight of described Borneolum Syntheticum are 1-3, and the parts by weight of described Mentholum are 1-4.
embodiment 2:
mosquito bite repellent antipruritic described in embodiment 1 is applied ointment or plaster, the parts by weight of described nitrofural are 2, and the parts by weight of described carbomer are 94, and the parts by weight of described lignocaine are 5, the parts by weight of described Borneolum Syntheticum are 2, and the parts by weight of described Mentholum are 2.5.
embodiment 3:
mosquito bite repellent antipruritic described in embodiment 1 is applied ointment or plaster, the parts by weight of described nitrofural are 1, and the parts by weight of described carbomer are 92, and the parts by weight of described lignocaine are 3, the parts by weight of described Borneolum Syntheticum are 1, and the parts by weight of described Mentholum are 2.
embodiment 4:
mosquito bite repellent antipruritic described in embodiment 1 is applied ointment or plaster, the parts by weight of described nitrofural are 3, and the parts by weight of described carbomer are 96, and the parts by weight of described lignocaine are 6, the parts by weight of described Borneolum Syntheticum are 3, and the parts by weight of described Mentholum are 4.
embodiment 5:
mosquito bite repellent antipruritic described in embodiment 1 is applied ointment or plaster, the parts by weight of described nitrofural are 2.5, and the parts by weight of described carbomer are 95, and the parts by weight of described lignocaine are 6, the parts by weight of described Borneolum Syntheticum are 2.5, and the parts by weight of described Mentholum are 3.
embodiment 6:
mosquito bite repellent antipruritic described in embodiment 1 is applied ointment or plaster, and also comprises medical adhesive-bonded fabric and nontoxic transparent whites Polypropylence Sheet.
embodiment 7:
the manufacture method that a kind of mosquito bite repellent antipruritic is applied ointment or plaster, taking by weight described nitrofural, described carbomer, described lignocaine, described Borneolum Syntheticum, described Mentholum packs in container and stirs fully and make mastic, be applied to uniformly on medical adhesive-bonded fabric, thickness is 3-5mm, then cover upper nontoxic transparent whites Polypropylence Sheet, then be tailored into the bulk of 30-50 × 30-50 mm, finally pack packaging bag into.
embodiment 8:
the manufacture method that mosquito bite repellent antipruritic described in embodiment 7 is applied ointment or plaster, described bulk is 30 × 30 mm.
embodiment 9:
the manufacture method that mosquito bite repellent antipruritic described in embodiment 7 is applied ointment or plaster, described bulk is 40 × 40 mm.
embodiment 10:
the manufacture method that mosquito bite repellent antipruritic described in embodiment 7 is applied ointment or plaster, described bulk is 50 × 50 mm.
embodiment 11:
mosquito bite repellent antipruritic described in above-described embodiment is applied ointment or plaster and manufacture method, and described carbomer is
carbomer Carbopol 940: short rheological characteristic, high viscosity, high clarity, low resistance to ionic and endurance of cutting.
or carbomer Carbopol 941: long rheological characteristic, low viscosity, high clarity, medium resistance to ionic and resistance to shearing.
or carbomer Carbopol 934: CP, local medicine-applying system, stable in the time of high viscosity.
or carbomer Carbopol 1342: CP, local medicine-applying system, fabulous rheology improver under electrolyte exists, polymerization emulsification.
or carbomer Carbopol 980: CP, local medicine-applying system, the clear and bright gel of crystallization.Or carbomer Carbopol ETD 2020: acrylate/C10-30 alkyl acrylate interlinkage copolymer, long rheological characteristic, low viscosity, high clarity, high resistance to ionic and endurance of cutting, be suitable for limpid gel.
or carbomer Carbopol AQUA SF-1: liquid, to grow rheological characteristic, can prepare limpid formula, the compatibility good with multiple components tool, returns acid-thickened.
or carbomer carbopol Ultrez 21: acrylate/C10-30 alkyl acrylate interlinkage copolymer, short rheological characteristic.
or carbomer Carbopol Ultrez 20: acrylate/C10-30 alkyl acrylate interlinkage copolymer, long rheological characteristic.
or carbomer Pemulen TR-1: acrylate/C10-30 alkyl acrylate interlinkage copolymer, thickening type emulsifying agent, short rheological characteristic.
or carbomer Pemulen TR-2: acrylate/C10-30 alkyl acrylate interlinkage copolymer, thickening type emulsifying agent, long rheological characteristic.
Claims (8)
1. a mosquito bite repellent antipruritic is applied ointment or plaster, its composition comprises: nitrofural, carbomer, lignocaine, Borneolum Syntheticum, Mentholum, it is characterized in that: the parts by weight of described nitrofural are 1-3, the parts by weight of described carbomer are 90-96, the parts by weight of described lignocaine are 3-7, the parts by weight of described Borneolum Syntheticum are 1-3, and the parts by weight of described Mentholum are 1-4.
2. mosquito bite repellent antipruritic according to claim 1 is applied ointment or plaster, it is characterized in that: the parts by weight of described nitrofural are 2, the parts by weight of described carbomer are 94, the parts by weight of described lignocaine are 5, the parts by weight of described Borneolum Syntheticum are 2, and the parts by weight of described Mentholum are 2.5.
3. mosquito bite repellent antipruritic according to claim 1 is applied ointment or plaster, it is characterized in that: the parts by weight of described nitrofural are 1, the parts by weight of described carbomer are 92, the parts by weight of described lignocaine are 3, the parts by weight of described Borneolum Syntheticum are 1, and the parts by weight of described Mentholum are 2.
4. mosquito bite repellent antipruritic according to claim 1 is applied ointment or plaster, it is characterized in that: the parts by weight of described nitrofural are 3, the parts by weight of described carbomer are 96, the parts by weight of described lignocaine are 6, the parts by weight of described Borneolum Syntheticum are 3, and the parts by weight of described Mentholum are 4.
5. mosquito bite repellent antipruritic according to claim 1 is applied ointment or plaster, it is characterized in that: the parts by weight of described nitrofural are 2.5, the parts by weight of described carbomer are 95, the parts by weight of described lignocaine are 6, the parts by weight of described Borneolum Syntheticum are 2.5, and the parts by weight of described Mentholum are 3.
6. mosquito bite repellent antipruritic according to claim 1 is applied ointment or plaster, and it is characterized in that: also comprise medical adhesive-bonded fabric and nontoxic transparent whites Polypropylence Sheet.
7. the manufacture method that mosquito bite repellent antipruritic is applied ointment or plaster, it is characterized in that: take by weight described nitrofural, described carbomer, described lignocaine, described Borneolum Syntheticum, described Mentholum and pack in container and stir fully and make mastic, be applied to uniformly on medical adhesive-bonded fabric, thickness is 3-5mm, then cover upper nontoxic transparent whites Polypropylence Sheet, then be tailored into the bulk of 30-50 × 30-50 mm, finally pack packaging bag into.
8. the manufacture method that mosquito bite repellent antipruritic according to claim 7 is applied ointment or plaster, is characterized in that: described bulk is 30 × 30 mm or 40 × 40 mm or 50 × 50 mm.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410157035.6A CN103919762A (en) | 2014-04-19 | 2014-04-19 | Application for diminishing swelling and relieving itching caused by mosquito bite and preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410157035.6A CN103919762A (en) | 2014-04-19 | 2014-04-19 | Application for diminishing swelling and relieving itching caused by mosquito bite and preparation method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103919762A true CN103919762A (en) | 2014-07-16 |
Family
ID=51138311
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410157035.6A Pending CN103919762A (en) | 2014-04-19 | 2014-04-19 | Application for diminishing swelling and relieving itching caused by mosquito bite and preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103919762A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1098911A (en) * | 1994-05-09 | 1995-02-22 | 杨明海 | Compounded painkilling and anti inflammatory cream |
| RU2438650C1 (en) * | 2011-01-12 | 2012-01-10 | Юлия Витальевна Шикова | Ointment with furacilin, lidocaine and dibunol for integrated treatment of maxillofacial abscesses and phlegmons |
-
2014
- 2014-04-19 CN CN201410157035.6A patent/CN103919762A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1098911A (en) * | 1994-05-09 | 1995-02-22 | 杨明海 | Compounded painkilling and anti inflammatory cream |
| RU2438650C1 (en) * | 2011-01-12 | 2012-01-10 | Юлия Витальевна Шикова | Ointment with furacilin, lidocaine and dibunol for integrated treatment of maxillofacial abscesses and phlegmons |
Non-Patent Citations (1)
| Title |
|---|
| 圣晶: "治疗蚊虫叮咬的特效药水", 《河南医药信息》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104428003B (en) | Diclofenac formulations | |
| CN105012993A (en) | Medical and antibacterial cationic biogel dressing and preparation method thereof | |
| CN105288695B (en) | Adhesive bandage of the ingredient containing graphene oxide and preparation method thereof | |
| BRPI0620403B8 (en) | bioadhesive film, dosage unit, method of manufacturing a bioadhesive film, and use of a composition | |
| CN103494668A (en) | Medical hydrogel moisturizing eye care mask and preparation method thereof | |
| MX2010004613A (en) | Topical composition. | |
| KR20130081653A (en) | Thermogelling anaesthetic compositions | |
| RU2009107699A (en) | APPLICATION OF EXTRACTS FOR TREATMENT OF VIRAL DISEASES | |
| Sharma et al. | Delivery of thermoresponsive-tailored mixed micellar nanogel of lidocaine and prilocaine with improved dermatokinetic profile and therapeutic efficacy in topical anaesthesia | |
| WO2012136934A3 (en) | Healing composition for topical application | |
| CN106377519B (en) | Anti-inflammatory disinfection removing miliaria and relieving itching aerosol of one kind and preparation method thereof | |
| CN105726513A (en) | Far-infrared inflammation diminishing and pain alleviating patch | |
| BR102018008324A2 (en) | topical pharmaceutical composition and topical pharmaceutical composition manufacturing process | |
| CN103919762A (en) | Application for diminishing swelling and relieving itching caused by mosquito bite and preparation method | |
| CN104382843B (en) | A kind of skin repair gel | |
| CN109010375A (en) | A kind of collyrium | |
| CN111297906B (en) | Bear gall cooling patch and preparation method thereof | |
| RU2605343C1 (en) | Agent for treating pyoinflammatory processes in soft tissues and mucous membranes | |
| AU2014216273A8 (en) | Topical ocular analgesic agents | |
| CN112957315A (en) | Personal care gel, preparation method and application | |
| CN101612240A (en) | A kind of medicine for external use for the treatment of herpes zoster | |
| CN104546880A (en) | External preparation for treating facial seborrheic dermatitis | |
| CN110141609A (en) | It is a kind of for treating the ointment and preparation method thereof that children canthus is split | |
| CN102475694A (en) | Externally applied patch for alleviating lumps and various pains | |
| CN102133324B (en) | Ointment for treating skin burns and scalds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140716 |